[1]赵华云,王文会,郎江明,等.参七汤干预冠心病支架植入术后再狭窄临床研究[J].中国中医药信息杂志,2010,17(2):18-20.
 ZHAO Hua-yun,WANG Wen-hui,LANG Jiang-ming,et al.Clinical Study of Shenqi Decoction in Treating Restenosis after Implantation of Stents in Patients with Coronary Artery Disease[J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):18-20.
点击复制

参七汤干预冠心病支架植入术后再狭窄临床研究

参考文献/References:

[1] Garza L, Aude YW, Saucedo JF. Can we prevent in-stent restenosis[J]. Curr Op in Cardiol,2002,17(5):518.

[2] 陈灏珠.内科学[M].第3版.北京:人民卫生出版社,1995.263-264.

[3] 中国中西医结合学会心血管病学会.冠心病中医诊断标准[J].中西医结合杂志,1991,11(5):257.

[4] 中国中西医结合学会活血化瘀专业委员会.血瘀证诊断标准[J].中西医结合杂志,1987,7(3):129.

[5] 沈自尹,王文健.中医虚证辨证参考标准[J].中西医结合杂志,1986, 6(10):598.

[6] 王 阶.活血化瘀研究与临床[M].北京:北京医科大学、中国协和医科大学联合出版社,1993.7.

[7] 潘 毅.心气虚证计量诊断再探[J].广州中医学院学报,1995,12(1):10.

[8] 李晓涛,夏 岳.炎症反应在冠脉支架置入术后再狭窄中的研究进展[J].心血管病学进展,2007,28(5):703-706.

[9] Osada M, Takeda S, Ogawa R. T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty[J]. J Interferon Cytokine Res,2001,21(4):219-221.

[10] Muller KM, Schmitz F. Morphological findings after stent implantation in the carotid artery[J]. Pathologe,2004,25(2):108-115.

[11] 陈协辉,王 伟,陈晓君,等.冠心病患者介入治疗前后血清C反应蛋白变化与心血管事件和再狭窄的关系[J].中国综合临床,2005,21(9):774-776.

[12] 鹿小燕,史大卓,徐 浩,等.芎芍胶囊干预冠心病介入治疗后再狭窄的研究[J].中国中西医结合杂志,2006,26(1):13-17.

[13] 陈伯均,阮新民,张敏州.益心祛瘀冲剂对冠心病PTCA术后再狭窄和血小板聚集影响的研究[J].南京中医药大学学报,2005,21(3):151-153.

[14] 秦 鉴,金明华,罗致强.复方参七胶囊对冠心病心绞痛疗效的临床观察及其对血脂水平的影响[J].中国中医药科技,1998,5(1):58-59.

[15] 赵华云,蔡 军,秦 鉴,等.参七汤影响缺血心肌内皮素基因表达的实验研究[J].中国中医急症,2005,14(8):764-765.

[16] 赵华云,蔡军,秦 鉴,等.参七汤抑制再灌注心肌细胞凋亡模型小鼠的实验研究[J].中国药房,2005,16(13):975-977.

相似文献/References:

[1]刘雪涛,叶祖光.冠心病心肌缺血的中医治法方药研究概述[J].中国中医药信息杂志,2010,17(5):106.
[2]姚欣艳,谭元生,高晓峰,等.十味温胆汤加味治疗冠心病稳定型心绞痛气虚痰瘀证临床研究[J].中国中医药信息杂志,2009,16(1):15.
 YAO Xin-yan,TAN Yuan-sheng,GAO Xiao-feng,et al.Clinical Study of Shiwei Wendan Decoction in Treating Coronary Heart Disease Stable Angina Pectoris of Qi Deficiency and Stasis-phlegm Type[J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):15.
[3]康兴霞,范平.怡心汤治疗冠心病心绞痛疗效观察[J].中国中医药信息杂志,2010,17(7):5.[doi:10.3969/j.issn.1005-5304.2010.07.003]
 KANG Xing-xia,FAN Ping.Clinical Observation of Yixin Tang in Treating Angina Pectoris of Coronary Heart Disease[J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):5.[doi:10.3969/j.issn.1005-5304.2010.07.003]
[4]郎立和.补阳还五汤临证举隅[J].中国中医药信息杂志,2010,17(7):88.[doi:10.3969/j.issn.1005-5304.2010.07.044]
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):88.[doi:10.3969/j.issn.1005-5304.2010.07.044]
[5]颜乾麟.颜德馨审机论治冠心病经验[J].中国中医药信息杂志,2009,16(2):88.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):88.
[6]张玉辉.曹洪欣治疗疑难病证5则[J].中国中医药信息杂志,2009,16(3):77.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):77.
[7]倪青,闫秀峰,林兰.芪蛭降糖胶囊治疗2型糖尿病合并冠心病心绞痛128例临床观察[J].中国中医药信息杂志,2010,17(10):9.[doi:10.3969/j.issn.1005-5304.2010.10.005]
 NI Qing,YAN Xiu-feng,LIN Lan.Clinical Study on the Effect of Qizhi Jiangtang Capsule in Treating 128 Patients with Diabetic Coronary Heart Disease and Angina[J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):9.[doi:10.3969/j.issn.1005-5304.2010.10.005]
[8]张明雪,曹洪欣,林巾孝,等.冠心病临床专家调查问卷信度效度分析[J].中国中医药信息杂志,2009,16(4):18.
 ZHANG Ming-xue,CAO Hong-xin,LIN Jin-xiao,et al.Analysis of Reliability and Validity for Clinical Experts Questionnaire about Coronary Heart Disease[J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):18.
[9]严洁,刁利红,常小荣,等.电针、复方丹参滴丸、针药结合对冠心病患者心肌耗氧量和临床症状积分的对照研究[J].中国中医药信息杂志,2007,14(2):14.
 YAN Jie,DIAO Li-hong,CHANG Xiao-rong,et al.Control Study of Three Different Treatment Method on MCO and ICS in Coronary Artery Disease[J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):14.
[10]杨俊华,杨国靖,刘茹.冠心病患者A型性格与情绪障碍及中医辨证分型关系的探讨[J].中国中医药信息杂志,2009,16(8):23.
 YANG Jun-hua,YANG Guo-jing,LIU Ru.The Relationship between A-type Character with Different Classification of TCM and Emotional Disturbance in Coronary Artery Disease Patients[J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):23.

备注/Memo

基金项目:广东省中医药管理局课题(2060007)

更新日期/Last Update: